Old Web
English
Sign In
Acemap
>
Paper
>
Is the EORTC QLQ-QNET21 Optimal for Patients with Neuroendocrine Tumors?
Is the EORTC QLQ-QNET21 Optimal for Patients with Neuroendocrine Tumors?
2018
R. Van Leeuwaarde
Francesca Spada
W. Cheung
A. Gonzalez-Clavijo
M. Pracht
G. Emelianova
Christina Thirlwell
Kjell Öberg
Keywords:
Oncology
Endocrinology
Internal medicine
Neuroendocrine tumors
Diabetes mellitus
Biology
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]